Mustang Bio Announces City of Hope Opens First-of-Its-Kind Multiple Myeloma CAR T Cell Therapy Trial Targeting CS1 Protein May 08, 2019
Checkpoint Therapeutics Announces Positive Interim Clinical Results of Anti-PD-L1 Antibody Cosibelimab May 01, 2019
St. Jude Children’s Research Hospital publishes results of Lentiviral Gene Therapy for Treatment of Infants with X-linked Severe Combined Immunodeficiency in New England Journal of Medicine Apr 17, 2019
Checkpoint Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference Apr 03, 2019
Mustang Bio Announces $20 Million Venture Debt Financing Agreement with Horizon Technology Finance Apr 01, 2019
